Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Agency Releases Early Communication on Possible Heart Risks

Nov. 23, 2009 -- A new study of the weight loss drug Meridia is in the hands of FDA regulators, who've released an early communication based on preliminary data: certain patients taking the drug may have a higher risk of heart attacks, strokes, and other serious cardiovascular problems.

The recent study tested Meridia (sibutramine) in overweight or obese people with an increased risk for heart problems. The agency warned that doctors and their patients should follow the current guidelines, which recommend against using Meridia in people with a history of coronary artery disease, congestive heart failure, heart rhythms disorders called arrhythmias, or stroke.

The FDA will continue to review findings from the SCOUT study, which was designed to test whether Meridia could help prevent heart problems by helping overweight and obese people lose weight. The FDA isn't making any conclusions about the early findings at this time. Analysis of the study's findings is ongoing.

European investigators followed about 10,000 people, age 55 or older, who had a history of heart disease or type 2 diabetes and one additional risk factor for heart disease. Half got sibutramine along with standard medical care for five years, while the other half took a sugar pill (a placebo) and got standard medical care. Serious cardiovascular events occurred in:

  • 11.4% of people taking Meridia
  • 10% of patients taking a sugar pill

A spokesman for Abbott Laboratories, the maker of sibutramine, says Meridia is safe when used in the appropriate group of people, as prescribed. According to Kurt Ebenhoch, the SCOUT study looked at high-risk patients who took the drug much longer than the one-year maximum use recommended in the U.S. "Sibutramine is not recommended or approved for use in more than 90% of the patients in the SCOUT study," Ebenhoch says.

Meridia works in the brain to help people feel full with less food. It's approved for use by obese people with a BMI (body mass index) of 30 or higher along with a weight loss diet and regular exercise. It's sometimes prescribed for people with BMIs as low as 27 when they have a weight-related condition like diabetes or sleep apnea.

WebMD Health News

Healthy Recipe Finder

Browse our collection of healthy, delicious recipes, from WebMD and Eating Well magazine.

Top searches: Chicken, Chocolate, Salad, Desserts, Soup

Heart Rate Calculator

Ensure you're exercising hard enough to get a good workout, but not strain your heart.

While you are exercising, you should count between...